GE HealthCare Technologies

At a glance

GE HealthCare Technologies reported 2025 revenue of $20.63B, up 4.8% from $19.67B in 2024. Over 4 years since 2021 ($17.59B), that is growth of about 4.1% a year. Operating margin was 13.4%, down from 15.9% in 2021. 2025 was the highest revenue year in this period.

In the last 12 months 8 insiders reported 8 open-market purchases ($6.4M) and 0 sales. The largest was a purchase of $5M by Director H Lawrence Culp Jr on May 7, 2026.

GE HealthCare Technologies filed 13 current reports (Form 8-K) in the last 12 months, most often for results of operations (5), officer or director change (5), material agreement (2) and new financial obligation (2). The latest officer or director change was reported on Oct 28, 2026. It reported a material agreement or a completed acquisition or disposal 2 times.

2 of the 20 investors tracked here held GE HealthCare Technologies at the last quarter end, worth $56.2M combined. It is the largest weight for National Pension Service (Korea) (0% of its portfolio), followed by Bridgewater Associates (0%). Added: National Pension Service (Korea). Reduced: Bridgewater Associates.

Annual results

Fiscal year ends Dec 31 · incorporated in DE

Tracked investors holding (13F)

Weight is the share of each investor's portfolio, as of the quarter end.